Microbot Medical Inc.

NasdaqCM MBOT

Microbot Medical Inc. Total Non-Current Liabilities for the quarter ending September 30, 2024

Microbot Medical Inc. Total Non-Current Liabilities is NA for the quarter ending September 30, 2024. Total non-current liabilities are the sum of long-term debt and other non-current liabilities.

Key data

Date	Total Non-Current Liabilities	Shareholders' Equity	Other Liabilities	Total Liabilities

NasdaqCM: MBOT

Microbot Medical Inc.

CEO	Mr. Harel Gadot
IPO Date	March 25, 1992
Location	United States
Headquarters	25 Recreation Park Drive
Employees	21
Sector	Technology
Industries Robotics 3D Printing Medical Instruments

Description

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.

Key trends

Past 5 years